Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-18
DOI
10.3389/fonc.2020.01495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients
- (2020) Cristiano Farace et al. Oncotarget
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Involvement of MAF1�homolog, negative regulator of RNA polymerase�III in colorectal cancer progression
- (2019) Kentaro Hokonohara et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
- (2019) Jianxing Yin et al. EBioMedicine
- MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
- (2019) Zhaojun Yin et al. OncoTargets and Therapy
- Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies
- (2019) Madhav Madurantakam Royam et al. Molecular Diagnosis & Therapy
- Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP
- (2019) Nasrin Zare et al. LEUKEMIA & LYMPHOMA
- A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer
- (2019) Guoying Jin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy
- (2019) Ana M S Cardoso et al. HUMAN MOLECULAR GENETICS
- microRNA‐16‐5p‐containing exosomes derived from bone marrow‐derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2
- (2019) Yan Xu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN
- (2019) Meiling Yang et al. LABORATORY INVESTIGATION
- SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression
- (2019) Yu Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
- (2019) Marcelo A. Mori et al. Cell Metabolism
- The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis
- (2019) Xianlong Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
- (2018) Philippe Icard et al. DRUG RESISTANCE UPDATES
- KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer
- (2018) Kege Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the RAS-dependent chemoresistance: The Warburg connection
- (2018) Roberto Serna-Blasco et al. SEMINARS IN CANCER BIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma
- (2018) Ailiang Zeng et al. CANCER LETTERS
- Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients
- (2018) Dengbo Ji et al. EBioMedicine
- Therapy resistance mediated by cancer stem cells
- (2018) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome
- (2018) Tingting Chen et al. EBioMedicine
- Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
- (2018) Pinar Kanlikilicer et al. EBioMedicine
- Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
- (2017) Xiaobing Qin et al. International Journal of Nanomedicine
- Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
- (2017) Haiyang Zhang et al. Nature Communications
- BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10
- (2016) Kai Wu et al. CANCER LETTERS
- MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
- (2016) L Venturutti et al. ONCOGENE
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma
- (2016) Zhi-Qiang Ning et al. Oncotarget
- Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer
- (2015) Dawei Yuan et al. CANCER BIOLOGY & THERAPY
- miR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis
- (2015) Abhisek Chatterjee et al. CELLULAR SIGNALLING
- Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
- (2015) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
- (2015) Cheng Wang et al. Scientific Reports
- Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
- (2015) Jialu Li et al. Scientific Reports
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
- (2013) N Takeshita et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of MicroRNA-16 Expression in Human Colorectal Cancer
- (2013) Jun Qian et al. WORLD JOURNAL OF SURGERY
- Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
- (2012) A Pagliuca et al. ONCOGENE
- Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma
- (2010) C. Zhang et al. CLINICAL CHEMISTRY
- A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis
- (2010) Rui Liu et al. EUROPEAN JOURNAL OF CANCER
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started